Mitsubishi Electric, Shizuoka Cancer Center to Co-develop Next-Generation Device for Proton Cancer Therapy.Tokyo, Japan, Dec 2, 2005 - (JCN JCN Japan Corporate News JCN Journal of Cognitive Neuroscience JCN Journal of Cardiovascular Nursing JCN Journal of Christian Nursing JCN Job Control Number JCN Journal of Child Neurology JCN joint communications network (US DoD) ) - Mitsubishi Electric Mitsubishi Electric Corporation (三菱電機株式会社 announced on December 1 that it has signed a joint development agreement with the Shizuoka Cancer Center. Under the agreement terms, the two partners will strive to develop an innovative device for proton proton, elementary particle having a single positive electrical charge and constituting the nucleus of the ordinary hydrogen atom. The positive charge of the nucleus of any atom is due to its protons. cancer therapy over the next five years. Specifically, they will proceed with research on proton beam scanning, a method that can effectively and selectively treat an affected area with a proton beam. For the first year or so, they will make a study on reducing time required for the therapy while improving precision. From then on, they will research on the radiation method and related technologies for clinical applications. With this move, the two partners aim to translate the proton therapy Proton therapy is a type of particle therapy which utilizes a beam of protons to irradiate a tumor site. Introduction Proton therapy is of interest because of its ability to accurately target and kill tumors, both near the surface and deep seated within the body, while into a standard cancer treatment. Copyright [c] 2005 Japan Corporate News Network. All rights reserved. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion